Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : Steve's Channelling Thread -- Ignore unavailable to you. Want to Upgrade?

To: Rick Storm who wrote (14610)	4/17/2001 8:04:56 PM
From: Casaubon	Respond to of 30051

Rick, Biotech stocks always go through a binge and purge cycle. If you can time the cycle well, you can make good coin. I mostly missed the bottom this time but that's OK because I would have played IMNX the day before it collapsed on terrible news from the clinic. Even though my TA was suggesting it was near the bottom, I was just too frightened to pull the trigger. So, I pretty much count myself lucky on this cycle. With biotechs, you are pretty much banking on future success from new drugs introduced to the market. For small companies this can have a dramatic impact on their financial position. Unfortunately, not many have managed to become profitable but there are some great ideas being researched.

To: Rick Storm who wrote (14610)	4/17/2001 8:07:55 PM
From: Zeev Hed	Respond to of 30051

It has been more than 10 years since the biotech served as the "tulips" of the day, thus they may be a candidate. I lean toward the optical companies, they are creating too many of these and before you know it, they will be fighting on limited capital to survive, but not before the street offers these to the mom and pop on a silver plate laced with cyanide. If the optics are indeed the next mania, you may want to be in their suppliers of "pick and shovels", namely, VECO and NEWP (one of the reasons for my interest in these two.) I am sure some other posters will have additional candidates tulips sectors (sorry, no turnips sectors this time). Zeev In edit, I just noted that casaubon pointed you onto a similar direction (biotech), if you are interested, i think that AMGN, QLTI (not really a biotech, but moves with them) and IDPH are ripe for good residual moves here, IMNX might have gone through its catharsis and could rise to just under $20 if the tulipication process is "imminent"